BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9110366)

  • 1. A new mutation C759T in the polymorphic N-acetyltransferase (NAT2) gene.
    Woolhouse NM; Qureshi MM; Bayoumi RA
    Pharmacogenetics; 1997 Feb; 7(1):83-4. PubMed ID: 9110366
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
    Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
    Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
    Vatsis KP; Martell KJ; Weber WW
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6333-7. PubMed ID: 2068113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of polymorphic variants C190T, G191A, G857A, and 859Del of the NAT2 gene by the method of restriction fragment length polymorphism.
    Nikishina MV; Vavilin VA; Lyakhovich VV
    Bull Exp Biol Med; 2008 Oct; 146(4):420-3. PubMed ID: 19489310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population.
    Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Roots I
    Pharmacogenetics; 1997 Aug; 7(4):327-31. PubMed ID: 9295061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
    Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
    Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters.
    Ferguson RJ; Doll MA; Baumstark BR; Hein DW
    Gene; 1994 Mar; 140(2):247-9. PubMed ID: 8144033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in NAT2 gene and atherosclerosis in an Algerian population.
    Khelil M; Zenati A; Makrelouf M; Otmane A; Tayebi B
    Arch Med Res; 2010 Apr; 41(3):215-20. PubMed ID: 20682180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
    Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y
    Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
    Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved detection of the T(341)C polymorphism in human N-acetyltransferase (NAT2) gene by using two complementary PCR-RFLP methods: better than automated DNA sequencing for detection of heterozygotes.
    Simsek M; Tanira MO; Al-Baloushi KA; Al-Barwani HS; Lawatia KM; Bayoumi RA
    Clin Biochem; 2000 Oct; 33(7):585-8. PubMed ID: 11124345
    [No Abstract]   [Full Text] [Related]  

  • 14. An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction.
    Abe M; Suzuki T; Deguchi T
    Jpn J Hum Genet; 1993 Jun; 38(2):163-8. PubMed ID: 8102908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.
    Doll MA; Fretland AJ; Deitz AC; Hein DW
    Anal Biochem; 1995 Nov; 231(2):413-20. PubMed ID: 8594994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
    Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and mapping of a cosmid clone containing the human NAT2 gene.
    Franke S; Klawitz I; Schnakenberg E; Rommel B; Van de Ven W; Bullerdiek J; Schloot W
    Biochem Biophys Res Commun; 1994 Feb; 199(1):52-5. PubMed ID: 7907215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyltransferase-2 polymorphism, smoking and type 1 diabetic nephropathy.
    Korpinen E; Groop PH; Rautio A; Madácsy L; Reunanen A; Vaarala O; Akerblom HK
    Pharmacogenetics; 1999 Oct; 9(5):627-33. PubMed ID: 10591543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
    Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
    Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.